Clinical trial
Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The…
NCT00169832 · Laval University, Other · Completed
Key facts
| NCT number | NCT00169832 |
|---|---|
| Title | Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial |
| Official title | A Multicenter Randomized Double-Blind Trial Comparing Rosiglitazone to Placebo for the Prevention of Atherosclerosis Progression After Coronary Bypass Surgery in Diabetic Patients |
| Acronym | VICTORY |
| Lead sponsor | Laval University, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Coronary Artery Bypass Grafting |
| Intervention type | Drug |
| Interventions | Rosiglitazone or placebo |
| Enrollment | 193 |
| Start date | Jun 1, 2003 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 10, 2008 |
| Countries | Canada, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: